Cancer Biology & Medicine: 22 (10)

October 15, 2025; Volume 22,Issue 10

Editorial

Open Access
Chimeric antigen receptor macrophages: a new frontier in hepatocellular carcinoma treatment
Rainbow Wing Hei Leung, Clarence Tsun Ting Wong and Terence Kin Wah Lee

Cancer Biology & Medicine October 2025, 22 (10) 1127-1131; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0427
Open Access
Advances in antibody-drug conjugates for urothelial carcinoma treatment
Jinchang Wei, Bixia Tang, Xieqiao Yan, Juan Li, Li Zhou, Siming Li, Huayan Xu and Xinan Sheng

Cancer Biology & Medicine October 2025, 22 (10) 1132-1142; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0284

Open Access
Current progress in neoantigen-based dendritic cell vaccines for solid tumors
Yuting Li, Abudukadierjiang Abudureheman and Jianming Xu

Cancer Biology & Medicine October 2025, 22 (10) 1143-1157; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0267
Open Access
Revisiting strategies to target ABC transporter-mediated drug resistance in CNS cancer
Haneen Amawi, Alaa M. Hammad, F. Scott Hall, Noor Hussein, Aseel O. Rataan, Abeer Mrayyan, Taqwa Al-kofahi, Ali Hmedat, Charles R. Ashby and Amit K. Tiwari

Cancer Biology & Medicine October 2025, 22 (10) 1158-1180; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0060
Open Access
Targeting mitochondrial dysfunction to intervene in liver cancer
Maomao Li, Siyao Liang, Le Chang, Bingyan Lu, Jiahua Cheng, Tian Yang, Ying Wu, Yuhong Lyu, Xiaochan He and Changwu Yue

Cancer Biology & Medicine October 2025, 22 (10) 1181-1209; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0180

Open Access
Radiomic model for preoperative prediction of mismatch repair deficiency in gastric cancer: a multicenter study integrating tumor sub-region radiomics and transcriptomics
Siwei Pan, Enze Li, Guoliang Zheng, Yi You, Yanqiang Zhang, Mengxuan Cao, Ruolan Zhang, Qing Yang, Yizhou Wei, Weiwei Zhu, Ke Shen, Chencui Huang, Jingxu Xu, Lijing Wang, Zaisheng Ye, Zhiyuan Xu and Can Hu

Cancer Biology & Medicine October 2025, 22 (10) 1210-1217; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0254
Open Access
Glofitamab vs. real-world regimens in Chinese patients with third- or later-line relapsed/refractory diffuse large B-cell lymphoma: an external control study
Keshu Zhou, Huijing Wu, Xia Zhao, Xiaohong Tan, Xiaojing Yan, Haisheng Liu, Liping Su, Yukun Lan, Jaihui Xu, Xiaohui Zhou, Yuerong Shuang and Huilai Zhang

Cancer Biology & Medicine October 2025, 22 (10) 1218-1222; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0104

Open Access
Cancer mortality trends in China from 2013–2021 and projections to 2030
Xin Liang, Yifei Yao, Xiang Li, Ting Gao and Xiaoqiu Dai

Cancer Biology & Medicine October 2025, 22 (10) 1223-1239; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0158
Open Access
Early-onset gastric cancer global burden profile, trends, and contributors
Xueyang Zhang, Boao Gao and Wei Wang

Cancer Biology & Medicine October 2025, 22 (10) 1240-1254; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0320
Open Access
Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma
Xiaoqing Ma, Chenyang Meng, Xuejing Shi, Zhaoyu Zhang, Qiuli Li, Hongwei Wang, Yuexiang Liang, Song Gao, Xiuchao Wang, Chuntao Gao, Jian Wang, Weidong Ma, Yukuan Feng, Shuo Li, Xingyun Chen, Wei Li, Shangheng Shi, Tianxing Zhou, Jun Yu and Jihui Hao

Cancer Biology & Medicine October 2025, 22 (10) 1255-1266; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0181